The phrase "an even higher efficacy" is correct and usable in written English.
It can be used when discussing the effectiveness or performance of a method, treatment, or product in comparison to others.
Example: "The new vaccine demonstrated an even higher efficacy than the previous version, leading to better health outcomes."
Alternatives: "a greater efficacy" or "an enhanced efficacy".
Although several publications from pilot studies in humans demonstrate the effects of artemisinin derivatives used alone [12], [13], pilot studies that were conducted with ACTs seem to demonstrate even higher efficacy [11], [14], [15].
would result in even higher efficacy.
Studies suggest that compared with the enantiomers, lower doses of levosulpiride can produce identical or even higher efficacy, greatly diminishing the occurrence of adverse events.
The potency among the tested inhibitors on the gatekeeper variant showed the biggest difference between PD173074 and TKI258, where the change of up to 225-fold reduction contrasts to no change or even higher efficacy towards the non-phospho form (Supplemental Table S1).
Although TRAIL induces apoptosis when given alone, it has been shown that combination of TRAIL with cytotoxic drugs as 5-fluorouracil, etoposide, paclitaxel, actinomycin C and cisplatin has an even higher apoptotic efficacy [ 50- 59, 6].
For even higher efficacies of adaptive immunity (I+{IA}), the evolutionary process gives rise to two divergent classes: hosts with adaptive immunity coexist with hosts that lack it, both exhibiting negligible suicide propensities.
With some simple strategic thought and planning, you can catapult a live event to an even higher level of efficacy and build your audience--as well as sustain and engage it long after they return to their offices.
Increasing screening participation to obtain an even higher degree of coverage will most likely increase the efficacy of the screening programme in decreasing the incidence of cervical cancer.
To understand why even high-efficacy (50%–90%) vaccines are only capable of reducing the TB death rate by one third, how the natural history of M. tuberculosis infection differs from other, more "simple," pathogens (e.g., influenza, measles, and smallpox) needs to be examined.
Recently, clinical studies assessing efficacy of HCV protease inhibitors in combination with PEG-IFN-α/RBV revealed an even higher rate of anemia ranging between 27%-46 27%-465].
